Citation 133945

HIRANO,T: ABE,K: GOTOH,M: OKA,K:. (1995). CITRUS FLAVONE TANGERETIN INHIBITS LEUKAEMIC HL-60 CELL GROWTH PARTIALLY THROUGH INDUCTION OF APOPTOSIS WITH LESS CYTOTOXICITY ON NORMAL LYMPHOCYTES.. 72(6)

Citation Details

Title	CITRUS FLAVONE TANGERETIN INHIBITS LEUKAEMIC HL-60 CELL GROWTH PARTIALLY THROUGH INDUCTION OF APOPTOSIS WITH LESS CYTOTOXICITY ON NORMAL LYMPHOCYTES.
Authors	HIRANO,T: ABE,K: GOTOH,M: OKA,K:
Year	1995
Volume	72
Issue	6

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	ACTIVE
2	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	INACTIVE
3	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	ACTIVE
4	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	ACTIVE
5	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	WEAK ACTIVITY
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TANGERETIN	INACTIVE
7	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	INACTIVE
8	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	WEAK ACTIVITY
9	CELL CYCLE CYTOTOXICITY(S PHASE)	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	WEAK ACTIVITY
10	CELL CYCLE CYTOTOXICITY(G2 + M PHASE)	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	WEAK ACTIVITY

Show SPARQL Queries (1)